1. Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR. 2002.
    Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.
    Infect Immun 70: 204-210.
  2. Brüssow H. 2005.
    Phage therapy: the Escherichia coli experience.
    Microbiology 151: 2133-2140.
  3. Bruttin A, Brüssow H. 2005.
    Human volunteers receiving Escherichia coli T4 phage orally: a safety test of phage therapy.
    Antimicrob Agents Chemother 49: 2874-2878.
  4. d’Hérelle F. 1925.
    Essai de traitement de la peste bubonique par le bactériophage.
    La Presse Med 33: 1393-1394.
  5. Górski A, Kniotek M, Perkowska-Ptasi?ska A, Mróz A, Przerwa A, Gorczyca W, Dabrowska K, Weber-Dabrowska B, Nowaczyk M. 2006.
    Bacteriophages and transplantation tolerance.
    Transplant Proc 38: 331-333.
  6. Hughes KA, Sutherland IW, Jones MV. 1998.
    Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase.
    Microbiol 144: 3039-3047.
  7. Krylov VN. 2001.
    Phage therapy in terms of bacteriophage genetics: hopes, prospects, safety, limitations.
    Russian J Genetics 37: 869-887.
  8. Merabishvili M, Pirnay J-P, Verbeken G, Chanishvili N, Tediashvili M, Lashkhi N, Glonti T, Krylov V, Mast J, Van Parys L, Lavigne R, Volckaert G, Mattheus W, Verween G, De Corte P, Rose T, Jennes S, Zizi M, De Vos D, Vaneechoutte M. 2009.
    Quality-controlled small-scale production of a well-defined bacteriophage cocktail for use in human clinical trials.
    PloS One 2009;4: e4944.
  9. Szczaurska-Nowak K, Dabrowska K, Celka M, Kurzepa A, Nevozhay D, Wietrzyk J, Switala-Jelen K, Syper D, Pozniak G, Opolski A, Górski A, Radzikowski C. 2009.
    Antitumor effect of combined treatment of mice with cytostatic agents and bacteriophage T4.
    Anticancer Res. 29: 2361-2370.
  10. Verbeken G, De Vos D, Vaneechoutte M, Merabishvili M, Zizi M, Pirnay J-P. 2007.
    The European regulatory conundrum of phage therapy.
    Future Microbiol 2: 485-491.
  11. Weber-Dabrowska B, Mulczyk M, Gorski A. 2000.
    Bacteriophage therapy of bacterial infections: an update of our institute’s experience.
    Arch Immunol Therap Experiment 48: 547-551.
  12. Wright A, Hawkins CH, Anggård EE, Harper DR. 2009.
    A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy.
    Clin Otolaryngol 34: 349-357.
  13. Chan BK, Abedon ST, Loc-Carrillo C. 2013.
    Phage cocktails and the future of phage therapy
    Future Med 8(6): 769-783
  14. Rose T, Verbeken G, De Vos D, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay J. 2014
    Experimental phage therapy of burn wound infection: difficult first steps 
    Int J Burn Trauma 4(2): 66-73.
  15. Sarkera SA, Sultanaa S, Reuteler G, Moinec D, Descombes P, Charton F, Bourdin G, McCallin S, Ngom-Bru C, Neville T, Akter M, Huq S, Qadri D, Talukdar K, Kassam M, Delley M, Loiseau C, Deng Y, El Aidy S, Berger B, Brüssow H. 2016.
    Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh
    EBioMedicine 4: 124–137.
  16. Abedon ST, Kuhl SJ, Blasdel BG, Kutter E. 2011.
    Phage treatment of human infections
    Bacteriophage 1(2): 66–85.
  17. Pirnay JP, Blasdel BG, Bretaudeau L, Buckling A, Chanishvili N, Clark JR, Corte-Real S, Debarbieux L, Dublanchet A, De Vos D, Gabard J, Garcia M, Goderdzishvili M, Górski A, Hardcastle J, Huys I, Kutter E, Lavigne R, Merabishvili M, Olchawa E, Parikka KJ, Patey O, Pouilot F, Resch G, Rohde C, Scheres J, Skurnik M, Vaneechoutte M, Van Parys L, Verbeken G, Zizi M, Van den Eede G. 2015.
    Quality and safety requirements for sustainable phage therapy products.
    Pharm Res 32(7):2173-9.
  18. Verbeken G1, Pirnay JP, Lavigne R, Jennes S, De Vos D, Casteels M, Huys I. 2014.
    Call for a dedicated European legal framework for bacteriophage therapy.
    Arch Immunol Ther Exp (Warsz). 62(2):117-29.
  19. Rose T, Verbeken G, Vos DD, Merabishvili M, Vaneechoutte M, Lavigne R, Jennes S, Zizi M, Pirnay JP. 2014.
    Experimental phage therapy of burn wound infection: difficult first steps.
    Int J Burns Trauma. 26;4(2):66-73. 


  1. Chanishvili N, Sharp R. 2009. Eliava Institute of Bacteriophage, Microbiology and Virology, Tbilisi, Georgia.  
    A literature review of the practical application of Bacteriophage Research.